Systematic Reviews
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 850-866
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.850
Table 3 Retrospective cohort studies
Ref.
Purpose
Type of study
Sample size
Conclusion
Setting
Guo et al[26]Assessment of VCS parameter for evaluation of sepsis in cirrhotic patientsRetrospective analysis of prospective data257 patientsProposed management was collection of blood culture, white cell volume determination, procalcitonin, and interleukin -6, sCD163 laboratory tests. Conclusion VCS parameters have the potential to be used to evaluate and predict early infections in patients with cirrhosis, and VCS can increase sensitivity and specificity in the diagnosis of sepsis and cirrhosis patientsICU
Villarreal et al[15]Assessing the usefulness of procalcitonin for diagnosing infection in cirrhotic patientsRetrospective cohort study66 patients of 255 admitted had procalcitonin tests. Patients with infection suspicion had a serum procalcitonin (PCT) test within the first 12 hSeptic patients with cirrhosis had elevated procalcitonin. As PCT has a sensitivity of 83% and specificity of 75% is an effective tool for diagnosing infection in patients with liver cirrhosis. Excellent tool for differentiating infectious disease in cirrhotic patientsICU
Galbois et al[27]Assess whether the mottling score and tissue oxygen saturation (StO2) may be used as early death predictors on cirrhotic patients with septic shock. Hemodynamic parameters at 6 h in patients with liver cirrhosis according to their survival status at 14 days42 out of 46 patients admitted with cirrhosis and septic shock were analyzedThere is systemic vasodilation and increased mortality in cirrhosis patients with sepsis. Patients with increased mottling died, and those with decreased survived. Mottling score and knee StO2 measures 6 h after starting vasopressors are excellent predictors of 14-day mortalityICU
Piccolo Serafim et al[14]The study evaluates the use of steroids in a patient with septic shock and cirrhosisA retrospective cohort study (2007-2017)56 patients out of 179 admitted with septic shock received steroids during ICUThe use of steroids did not show significant differences in mortality. Vasopressor requirement and is not associated with decreased mortalityICU
Chang et al[17]aimed to determine whether septic patients with liver cirrhosis had worse survival than patients without liver cirrhosisRetrospective cohort776 patients, 64 had sepsis with cirrhosis, 712 sepsis without cirrhosisCirrhotic patients with sepsis had a poor outcome, and the survival of sepsis and cirrhosis after matching was not inferior to those without cirrhosisICU
Sauneuf et al[18]Assess the use of albumin as an adjuvant to vasopressors in managing septic shock in cirrhotic patientsRetrospective cohort single center and observational overdone over 14 years studied done from 1997 to 2004 and 2005 to 2010During the period 2005 to 2010, 42, cirrhotic patients with septic shock in ICU were includedIn conclusion, the survival rate of septic shock in cirrhosis remains low, and current shock management could benefit cirrhotic patients. Treatment use is: Vasopressors used is norepinephrine, epinephrine, and dobutamine; mechanical ventilation was used in the case of ARDS, and a protective strategy with a low tidal volume of 6 m/kg of body weight, and the plateau was kept below 30 cmH2O, small -dose of corticosteroids (200 mg hydrocortisone per day, insulin therapy, The main sites of infections were: Pneumonia, spontaneous or secondary peritonitis, and urinary tract infection. There were gram-positive and negative. Septic shock represent a severe complication of cirrhosis with very low survival rates. Sepsis in a cirrhotic patient has a poor prognosis. Hydrocortisone did not reduce mortality and was associated with adverse effects such as shock relapse and gastrointestinal bleeding. Cirrhotic patients are commonly perceived as poor candidates for `ICU admission because of the very high mortalityICU
Umgelter et al[21]Assess the outcome of the continuous low dose of TP in a septic shock patientSmall cohort study2004-2007: 12 patients, 8 males, and 4 females were included with sepsis due to spontaneous bacterial peritonitis, pneumonia, and cholangitisTP is currently used in treating cirrhotic patients with hepatorenal syndrome and as an adjunct to NE in a cirrhotic patient with septic shock and kidney failure; TP dose 2 ug/kg if a patient was started NE in the first 24 h. 11 patients had RRT, TP increased SVR index and NE doses needed to obtain target MAP decreased while the CI remained stable. Despite hemodynamic improvement, 11 out of 12 patients died. The author concluded that TP was effective as a vasopressor in septic cirrhotic patients at a low dose in combination with NE, and there was no dramatic decrease in CI. TP has a role in the early treatment of septic shock, and the author recommends a controlled study with TP in a cirrhotic patient with sepsisICU
Durst et al[20]The study aimed to evaluate the use of vasopressor in septic shock with cirrhosis and without cirrhosissingle-center, retrospective cohort, 18 years122 patients included were 61 with cirrhosis and 61 non-cirrhosis with sepsis, and septic with cirrhosisICU
Maimone et al[12]Compare the 20% albumin to plasmolytes in managing cirrhosis and sepsis in the intensive care unitRetrospective cohort study100 patients with cirrhosis and sepsis-induced hypotensionICU
Bal et al[24]The aim is to predict 50 days in hospital mortality in decomposed cirrhosis patients with SBPA single-centre study prospective study218 were admitted to ICU from 2013-2014 with cirrhosis and spontaneous bacterial peritonitisICU
Chebl et al[22]Assess the outcome and mortality predictor of cirrhosis patients with sepsisA single-center retrospective cohort study200 patientsThe study revealed an increased risk of sepsis in cirrhotic patients and sepsis-induced organ failure and related death in cirrhosis. The management of shock is to keep MAP above 65 mmgh with vasopressors; the aggressive fluid hydration may worsen the outcome as there is low oncotic pressure in a cirrhotic patient, which may lead to oedema with aggressive fluid hydration, so it is good to start with vasopressors early in the treatment of septic cirrhosis patients to avoid complications, a cirrhotic patient has higher lactate than the non-cirrhotic because of decreased lactate clearance by the liverICU
Chen et al[25]A single-center, retrospective cohort study from 2015 to 2018104 patients with cirrhosis and bacteremia were subdivided into afebrile (55) and febrile (49)The cirrhotic patient is prone to infection. Cirrhotic patients with bacterial infections present with atypical manifestations such as normothermia. Scoring systems focused on organ dysfunction, such as quick sequential organ failure assessment (qSOFA) score or chronic liver failure sequential organ failure assessment (CLIF-SOFA) score, have better predictor abilityIn the emergency department
Sasso et al[19]Assess the prediction of mortality in a cirrhotic patientProspective cohort113 patients mechanically ventilator cirrhotic from 2014-2018Conclude that cirrhotic patients requiring mechanical ventilation have an extremely poor prognosis, and the vasopressor requirement was strongly a predictor of mortality in mechanical ventilation cirrhosis with sepsisICU
Fischer et al[12]Assess the use of presepsin and resistin as markers of bacterial infections in cirrhotic patients with sepsisConclusion: Both presepsin and resistin may be reliable markers of bacterial infections in patients with decompensated liver cirrhosis and have similar diagnostic performance for bacterial infection and sepsis compared to C-reactive protein (CRP) and PCT. The best cut-off level of presepsin for diagnosis of sepsis was 1444 pg/mL. Conclusion PCT, CRP, Presepsin, and resistin had similar accuracy in diagnosing infection and sepsis in decompensated cirrhosisICU
Baudry et al[9]Assess the prognosis of sepsis in cirrhotic patientsA Retrospective cohort study from 2002-20137644 patients were admitted, where 149 wereICU